What changed
$PH — AVOID 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $5.5B | EPS $8.17 vs $7.83 🟢
💡 Consensus was too low for Q3 2026, but forward estimates have probably adjusted. There is no evidence of a persistent gap between current market expectations and reality—quant ranks at 0th percentile suggest the stock is already fully valued or overvalued.
📉 Reward/risk: 0.95:1
🏢 Business Quality: 8/10
📊 Valuation: rich — ttm P/E estimated ~30x, above 5-year average ~22x and sector median ~20x; EV/EBITDA and FCF yield also suggest a premium; fair value range...
💰 Entry: $961.09, stop $920, target $1000
⚖️ Avoid: stale earnings beat, rich valuation, no near-term catalyst; better opportunities elsewhere.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/PH0625